A deeper understanding of amino acid transporters’ roles in metabolic processes and insulin signaling could shed light on the pathogenesis of diabetes and unveil novel therapeutic targets for this pervasive metabolic syndrome. This evidence concerns the gene INS and diabetes mellitus.